Lupin . Stock Sees Positive Trend, Rated 'Buy' by MarketsMOJO

Lupin ., a leading pharmaceutical company in the largecap industry, has seen a positive trend in its stock performance on October 9th, 2024. The stock has gained 3.1%, closing at Rs 2292. This has been reflected in the stock call given by MarketsMOJO, which has rated Lupin . as a 'Buy'.

In terms of price, Lupin . is currently 0.77% away from its 52-week high of Rs 2312. The stock has also outperformed the sector by 0.84% today. It has been on a consecutive gain for the last 2 days, with a 5.73% increase in returns during this period. The stock also touched an intraday high of Rs 2297, showing a 3.16% increase.

Lupin . is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock performance. In the pharmaceuticals and drugs sector, Lupin . has gained by 2.06%.

In comparison to the overall market performance, Lupin . has outperformed the Sensex by 2.76% in the last 1 day and 3.20% in the last 1 month. This shows the strong performance of the company's stock in the market.

With its consistent growth and positive trend, Lupin . continues to be a strong player in the pharmaceutical industry. Investors can consider this stock as a potential 'Buy' option, as suggested by MarketsMOJO.